The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Murkamilov I.T.

I.K. Akhunbaev Kyrgyz state medical academy, Bishkek, Kyrgyz Republic;
Salymbekov University, Bishkek, Kyrgyz Republic

Aitbaev K.A.

I.K. Akhunbaev Kyrgyz state medical academy, Bishkek, Kyrgyz Republic

Fomin V.V.

Russian Medical Academy of Continuing Professional Education, Moscow, Russia

Murkamilova Zh.A.

Family Medicine Center No. 7, Bishkek, Kyrgyz Republic

Rayimzhanov Z.R.

N.N. Burdenko Main Military Clinical Hospital, Moscow, Russia

Yusupov A.F.

Osh State University, Osh, Kyrgyz Republic

Yusupova Z.F.

Osh State University, Osh, Kyrgyz Republic

Yusupova T.F.

Osh State University, Osh, Kyrgyz Republic

Yusupov F.A.

Osh State University, Osh, Kyrgyz Republic

Gassanov K.A.

I.K. Akhunbaev Kyrgyz state medical academy, Bishkek, Kyrgyz Republic

Morphofunctional features of the left ventricle in patients with chronic cerebral ischemia

Authors:

Murkamilov I.T., Aitbaev K.A., Fomin V.V., Murkamilova Zh.A., Rayimzhanov Z.R., Yusupov A.F., Yusupova Z.F., Yusupova T.F., Yusupov F.A., Gassanov K.A.

More about the authors

Read: 305 times


To cite this article:

Murkamilov IT, Aitbaev KA, Fomin VV, et al. Morphofunctional features of the left ventricle in patients with chronic cerebral ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2026;126(3‑2):12‑20. (In Russ.)
https://doi.org/10.17116/jnevro202612603212

Recommended articles:
Prevalence and characteristics of risk factors for cere­brovascular disease in overweight. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):118-124
Diagnosis and treatment of ovarian cancer in pregnancy. Russian Bulletin of Obstetrician-Gynecologist. 2025;(3):27-33

References:

  1. Gusev EI, Chukanova AS. Modern pathogenetic aspects of development of cerebral chronic ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2015;115(3):4-8. (In Russ.). https://doi.org/10.17116/jnevro2015115314-8
  2. Kamchatnov PR, Vorob’eva OV, Rachin AP. Treatment of emotional and cognitive disorders in patients with chronic cerebral ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2014;114(4):52-56. (In Russ.).
  3. Danilov AB, Shindryaeva NN, Borodulina IV, et al. Clinical efficacy and safety of Picamilon in patients with progressive chronic cerebral ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(8):71-80. (In Russ.). https://doi.org/10.17116/jnevro202412408171
  4. Malashenkova IK, Krynskiy SA, Ogurtsov DP, et al. Immunological and neuroanatomic markers of the clinical dynamics of MCI and pre-MCI. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(8):81-91. (In Russ.). https://doi.org/10.17116/jnevro202412408181
  5. Zakharov VV, Sleptsova KB, Martynova OO. Chronic cerebral ischemia: a view from the XXI century. RMJ. 2021;5:45-49. (In Russ.).
  6. Kamchatnov PR, Umarova HYa, Osmaeva ZKh. Correction of cognitive and affective disorders in patients with chronic cerebral ischemia. Neurology and Rheumatology (Suppl Consilium Medicum). 2018;2: 5-9. (In Russ.).
  7. Murkamilov IT, Aitbaev KA, Murkamilova ZhA, et al. Chronic cerebral ischemia in therapeutic hospital patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(3-2):50-57. (In Russ.). https://doi.org/10.17116/jnevro202312303250
  8. Clinical recommendations. Chronic kidney disease (CKD). Nefrologiya. 2021;25(5):10-82. (In Russ.).
  9. Kobalava ZhD, Konradi AO, Nedogoda SV, et al. 2024 Clinical practice guidelines for Hypertension in adults. Rossijskij kardiologicheskij zhurnal. 2024;29(9):6117. (In Russ.). https://doi.org/10.15829/1560-4071-2024-6117
  10. Chernyavsky MA, Irtyuga OB, Yanishevsky SN, et al. Russian consensus statement on the diagnosis and treatment of patients with carotid stenosis. Rossijskij kardiologicheskij zhurnal. 2022;27(11):5284. (In Russ.). https://doi.org/10.15829/1560-4071-2022-5284
  11. Kamchatnov PR. Chronic Cerebral Circulation Disorders: Possibilities of Metabolic Therapy. RMJ. 2008;5:274. (In Russ.).
  12. Kamchatnov PR, Evzelman MA, Morozova YuA. Chronic cerebral circulatory disorders: possibilities of enhancing the efficiency of therapy. Nevrologiya, neiropsikhiatriya, psikhosomatika. 2017;9(3):105-110.(In Russ.). https://doi.org/10.14412/2074-2711-2017-3-105-110
  13. Semushkina EG, Bogolepova AN. Cardiac disorders and cognitive impairment in patients with chronic cerebral ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2013;113(2):9-13. (In Russ.).
  14. Kostenko EV, Polunin VS, Polunina NV. Impact of Comorbidities on Rehabilitation after Stroke. Lechebnoe delo. 2017;4:27-33. (In Russ.).
  15. Tolpygina SN, Zagrebelny AV, Chernysheva MI, et al. Comorbidity and long-term survival of patients suffered from acute cerebrovascular accident based on the REGION-M registry. Russian Journal of Preventive Medicine. 2023;26(11):64-68. (In Russ.). https://doi.org/10.17116/profmed20232611164
  16. Martynov AI, Tanashyan MM, Malyavin AG, et al. Resolution of the expert council «Possibilities of neuroprotective therapy in patients with arterial hypertension and cognitive disorders». Russian Journal of Preventive Medicine. 2024;27(11):85-93. (In Russ.). https://doi.org/10.17116/profmed20242711185
  17. Levin OS. Pathology of white substance in dyscirculatory encephalopathy: diagnostic and treatment aspects. Trudnyj patsient. 2011;9:12:16-23. (In Russ.).
  18. Willeit J, Kiechl S. Prevalence and risk factors of asymptomatic extracranial carotid artery atherosclerosis. A population-based study. Arterioscler Thromb. 1993 May;13(5):661-668.  https://doi.org/10.1161/01.atv.13.5.661
  19. Handa N, Matsumoto M, Maeda H, et al. Ischemic stroke events and carotid atherosclerosis. Results of the Osaka Follow-up Study for Ultrasonographic Assessment of Carotid Atherosclerosis (the OSACA Study). Stroke. 1995 Oct;26(10):1781-1786. https://doi.org/10.1161/01.str.26.10.1781
  20. Ershova AI, Boytsov SA, Drapkina OM, Balakhonova TV. Ultrasound markers of premanifest atherosclerosis of carotid and femoral arteries in assessment of cardiovascular risk. Rossijskij kardiologicheskij zhurnal. 2018;(8):92-98. (In Russ.). https://doi.org/10.15829/1560-4071-2018-8-92-98
  21. Spence JD, Eliasziw M, DiCicco M, et al. Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy. Stroke. 2002 Dec;33(12): 2916-2922. https://doi.org/10.1161/01.str.0000042207.16156.b9
  22. Levy D, Anderson KM, Savage DD, et al. Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol. 1987 Sep 01;60(7):560-5.  https://doi.org/10.1016/0002-9149(87)90305-5
  23. Nwabuo CC, Vasan RS. Pathophysiology of Hypertensive Heart Disease: Beyond Left Ventricular Hypertrophy. Curr Hypertens Rep. 2020 Feb 03; 22(2):11.  https://doi.org/10.1007/s11906-020-1017-9
  24. Bots ML, Nikitin Y, Salonen JT, et al. Left ventricular hypertrophy and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe. J Epidemiol Community Health. 2002 Feb;56 (Suppl 1):i8-i13.  https://doi.org/10.1136/jech.56.suppl_1.i8
  25. Safarova AF, Kotovskaya YuV, Korovina EP. Sovremennye metody diagnostiki gipertrofii miokarda levogo zheludochka u bol’nykh arterial’noj gipertoniej. Moscow; 2009. (In Russ.).
  26. Devereux RB, de Simone G, Ganau A, Roman MJ. Left ventricular hypertrophy and geometric remodeling in hypertension: stimuli, functional consequences and prognostic implications. J Hypertens Suppl. 1994 Dec; 12(10):S117-S127.
  27. Kohara K, Zhao B, Jiang Y, et al. Relation of left ventricular hypertrophy and geometry to asymptomatic cerebrovascular damage in essential hypertension. Am J Cardiol. 1999 Feb 01;83(3):367-370.  https://doi.org/10.1016/s0002-9149(98)00870-4
  28. Huang J, Robert C, Ling LH, et al. Cross-Sectional Association Between Left Ventricular Geometric Patterns, Cortical Cerebral Microinfarcts, and Cognition. J Am Heart Assoc. 2025 Jan 21;14(2):e035522. https://doi.org/10.1161/JAHA.124.035522
  29. Gillebert TC, Chirinos JA. Left Ventricular Geometry, Blood Pressure, Arterial Hemodynamics, and Mortality After Ischemic Stroke. JACC Cardiovasc Imaging. 2018 Mar;11(3):383-385.  https://doi.org/10.1016/j.jcmg.2017.03.013
  30. Nakanishi K, Jin Z, Homma S, et al. Left ventricular mass-geometry and silent cerebrovascular disease: The Cardiovascular Abnormalities and Brain Lesions (CABL) study. Am Heart J. 2017 Mar;185:85-92.  https://doi.org/10.1016/j.ahj.2016.11.010
  31. Akinboboye OO, Chou RL, Bergmann SR. Myocardial blood flow and efficiency in concentric and eccentric left ventricular hypertrophy. Am J Hypertens. 2004 May;17(5 Pt 1):433-438.  https://doi.org/10.1016/j.amjhyper.2004.02.006
  32. Savage DD, Garrison RJ, Kannel WB, et al. The spectrum of left ventricular hypertrophy in a general population sample: the Framingham Study. Circulation. 1987 Jan;75(1 Pt 2):I26-I33. 
  33. Vetoshkin AS, Shurkevich NP, Gapon LI, Simonyan AA. Carotid atherosclerosis, arterial hypertension, and left ventricular remodeling in men working on a rotational basis in the Far North. Sibirskij meditsinskij zhurnal. 2020;35(1):159-166. (In Russ.). https://doi.org/10.29001/2073-8552-2020-35-1-159-166
  34. Sadokha KA, Makarov AP, Makarova AN. Chronic cerebral ischemia: the current state of the problem. Meditsinskie novosti. 2024;1:23-28. (In Russ.).
  35. Murkamilov IT, Fomin VV, Yusupov FA, Sabirov IS. Predictors of cardiovascular complications in patients with arterial hypertension and comorbid pathology. Sistemnye gipertenzii. 2021;18(4):180-185. (In Russ.). https://doi.org/10.26442/2075082X.2021.4.201299
  36. Murkamilov IT, Aitbaev KA, Fomin VV, et al. Sex and age characteristics of stroke risk factors in patients with type 2 diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(8 vyp 2):60-67. (In Russ.). https://doi.org/10.17116/jnevro202512508289
  37. Pavlova TV, Duplyakov DV. Left Ventricular Hypertrophy and Antihypertensive Therapy Options. Effektivnaia farmakoterapiia. 2010;10:16-21. (In Russ.).
  38. Kuznetsova AV, Kostomarova IV, Senko OV. Logical statistics analysis of the correlation between clinical laboratory rates and blood circulation disorders in senile patients with chronic cerebral ischemia. Matematicheskaya biologiya i bioinformatika. 2013;8(1):182-224. (In Russ.).
  39. Kovalchuk VV, Barantsevich YeR. Chronic Cerebral Ischemia. Current Understanding of Etiopathogenesis, Diagnostics and Therapy. Effektivnaya farmakoterapiya. 2017;(19):26-33 (In Russ.).
  40. Kamchatnov PR, Kudryavtsev SV. Management of an elderly patient with chronic cerebral ischemia: selection of a nootropic drug. Consilium Medicum. 2012;14(9):23-27. (In Russ.).

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.